SCHEMBL20195347

SCHEMBL20195347

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4ccc(-c5cc(-c6ccccn6)cc(-c6ccccn6)c5)c5ccccc45)c3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
TDP1 Q9NUW8 2/20 0.44
MAPK1 P28482 3/20 0.44
HSD17B10 Q99714 3/20 0.44
TSHR P16473 2/20 0.44
SMN1; SMN2 Q16637 8/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
METAP1 P53582 2/20 0.43
TP53 P04637 4/20 0.41
PKM P14618 2/20 0.41
DHODH Q02127 1/20 0.41
LMNA P02545 5/20 0.41
HTT P42858 2/20 0.41
ALPL P05186 1/20 0.41
HSP90AA1 P07900 1/20 0.41
ALPI P09923 1/20 0.41
ALPG P10696 1/20 0.41
ALOX15 P16050 1/20 0.41
CCR1 P32246 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21098923 0.97 HSD17B10 (0.42) KDM4ETDP1MAPK1HSD17B10TSHR
SCHEMBL21099075 0.93 MAPK1 (0.49) KDM4ETDP1MAPK1HSD17B10TSHR
SCHEMBL21099056 0.93 KDM4E (0.46) KDM4ETDP1MAPK1HSD17B10TSHR
SCHEMBL18679984 0.92 KDM4E (0.46) KDM4ETDP1MAPK1HSD17B10TSHR
SCHEMBL21099073 0.92 MAPK1 (0.48) KDM4ETDP1MAPK1HSD17B10TSHR
SCHEMBL20195361 0.91 KDM4E (0.44) KDM4ETDP1MAPK1HSD17B10TSHR
SCHEMBL21099059 0.91 SMN1; SMN2 (0.46) KDM4ETDP1MAPK1HSD17B10TSHR
SCHEMBL18680012 0.89 KDM4E (0.44) KDM4ETDP1MAPK1HSD17B10TSHR
SCHEMBL18680013 0.89 KDM4E (0.44) KDM4ETDP1MAPK1HSD17B10TSHR
SCHEMBL18679997 0.89 METAP1 (0.44) KDM4ETDP1MAPK1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323006-B2 Heterocyclic compound and organic light emitting element using same LG CHEM, LTD. (KR) 2019-06-18 US disclosed
EP-3327008-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME LG Chem, Ltd. (KR) 2018-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10323006-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, NR2E3 KDM4E 1017/4885TDP1 3533/4885MAPK1 3653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.